1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, then it is likely to cause adverse effects as well.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the central nervous system, such as a piperazine group, then it is likely to cause adverse effects as well.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on both the immune system and the central nervous system, such as a quinolone group, then it is likely to cause adverse effects as well.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to immune system disorders.
Explanation:
1. The first rule is based on the fact that carboxylic acid groups are commonly found in drugs and are known to cause adverse effects related to immune system disorders. The molecule in question, CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN 1, contains a carboxylic acid group. Therefore, it is likely to cause adverse effects related to immune system disorders.
2. The second rule is based on the fact that nitro groups are commonly found in drugs and are known to cause adverse effects related to immune system disorders. The molecule in question, C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O 1, contains a nitro group. Therefore, it is likely to cause adverse effects related to immune system disorders.
3. The third rule is based on the fact that halogenated aromatic rings are commonly found in drugs and are known to cause adverse effects related to immune system disorders. The molecule in question, CCCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO 1, contains a halogenated aromatic ring. Therefore, it is likely to cause adverse effects related to immune system disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If a molecule contains a benzene ring, it is likely to cause adverse effects related to immune system disorders.
Explanation:
- Rule 1: The presence of a nitro group (-NO2) in a molecule is often associated with adverse effects related to immune system disorders. Nitro groups can interact with the immune system and cause inflammation, which can lead to various health problems.
- Rule 2: Chlorine atoms are often found in molecules that are associated with adverse effects related to immune system disorders. Chlorine atoms can interact with the immune system and cause inflammation, which can lead to various health problems.
- Rule 3: Benzene rings are commonly found in molecules that are associated with adverse effects related to immune system disorders. Benzene rings can interact with the immune system and cause inflammation, which can lead to various health problems.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to immune system disorders.
These rules are based on the observation that the molecules with these functional groups are more likely to cause adverse effects related to immune system disorders. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the adverse effects of a molecule.

================================

1. Rule 1: If the molecule contains an aromatic ring, it is more likely to cause adverse effects.
2. Rule 2: If the molecule has a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If the molecule has a high molecular weight, it is more likely to cause adverse effects.
Explanation:
1. Rule 1: The presence of an aromatic ring in a molecule can increase its lipophilicity, which can lead to increased absorption and distribution in the body. This can result in adverse effects such as toxicity, carcinogenicity, and genotoxicity.
2. Rule 2: Polar functional groups such as alcohols, aldehydes, and carboxylic acids can increase the polarity of a molecule, making it more water-soluble and potentially more toxic.
3. Rule 3: High molecular weight molecules are typically larger and more complex than low molecular weight molecules, which can make them more difficult to absorb and distribute in the body. This can result in adverse effects such as toxicity, carcinogenicity, and genotoxicity.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to immune system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1) contains a carboxylic acid group (-COOH), which is known to cause adverse effects related to immune system disorders.
2. Rule 2: The second molecule (CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O) contains a nitro group (-NO2), which is known to cause adverse effects related to immune system disorders.
3. Rule 3: The third molecule (CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])S[C@H]3C[C@@H](O[C@@H]3COP(=O)([O-])S[C@H]4C[C@@H](O[C@@H]4COP(=O)([O-])S[C@H]5C[C@@H](O[C@@H]5COP(=O)([O-])S[C@H]6C[C@@H](O[C@@H]6COP(=O)([O-])S[C@H]7C[C@@H](O[C@@H]7COP(=O)([O-])S[C@H]8C[C@@H](O[C@@H]8COP(=O)([O-])S[C@

================================

1. Rule 1: If the molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, then it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a quinolone group, then it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a functional group that is known to cause adverse effects on the skin, such as a benzimidazole group, then it is likely to cause adverse effects.
These rules are based on the assumption that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not foolproof and there may be exceptions to them. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to immune system disorders.
Explanation:
- Rule 1: The presence of a carboxylic acid group (-COOH) in a molecule is often associated with adverse effects related to immune system disorders. This is because carboxylic acids can interact with immune cells and affect their function. For example, some antibiotics such as penicillins and cephalosporins contain a carboxylic acid group and are known to cause adverse effects such as rash, fever, and allergic reactions.
- Rule 2: The presence of a nitro group (-NO2) in a molecule is also associated with adverse effects related to immune system disorders. Nitro groups can interact with immune cells and affect their function, leading to inflammation and other adverse effects. For example, some antidepressants such as amitriptyline and nortriptyline contain a nitro group and are known to cause adverse effects such as nausea, vomiting, and dizziness.
- Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule is associated with adverse effects related to immune system disorders. Halogen atoms can interact with immune cells and affect their function, leading to inflammation and other adverse effects. For example, some anti-inflammatory drugs such as aspirin and ibuprofen contain a halogen atom and are known to cause adverse effects such as stomach ulcers and bleeding.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to immune system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule C1C(C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)O)O)N 0 contains a carboxylic acid group (-COOH). This suggests that it may have adverse effects related to immune system disorders.
2. Rule 2: The molecule CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)C)O)(C)O 1 contains a nitro group (-NO2). This suggests that it may have adverse effects related to immune system disorders.
3. Rule 3: The molecule C(=O)([O-])[O-].[Na+].[Na+] 0 contains a halogen atom (fluorine). This suggests that it may have adverse effects related to immune system disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to immune system disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to immune system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl, contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: The molecule with label 0, CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C, contains a chlorine atom (Cl). Therefore, it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: The molecule with label 0, CC(C)(CC1=CC=CC=C1)N, contains a benzene ring (C6H5). Therefore

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to skin and eye irritation.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to liver damage.
These rules are based on the data provided and can be used to predict whether a new molecule is likely to cause adverse effects based on its structure. However, it is important to note that these rules are not foolproof and should be used with caution. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to immune system disorders.
Explanation:
1. The first rule is based on the fact that carboxylic acid groups are commonly found in drugs and are known to cause adverse effects related to immune system disorders. The second rule is based on the fact that nitro groups are also commonly found in drugs and are known to cause adverse effects related to immune system disorders. The third rule is based on the fact that halogenated aromatic rings are commonly found in drugs and are known to cause adverse effects related to immune system disorders.
2. The first rule is based on the fact that the molecule contains a carboxylic acid group, which is known to cause adverse effects related to immune system disorders. The second rule is based on the fact that the molecule contains a nitro group, which is known to cause adverse effects related to immune system disorders. The third rule is based on the fact that the molecule contains a halogenated aromatic ring, which is known to cause adverse effects related to immune system disorders.
3. The first rule is based on the fact that the molecule contains a carboxylic acid group, which is known to cause adverse effects related to immune system disorders. The second rule is based on the fact that the molecule contains a nitro group, which is known to cause adverse effects related to immune system disorders. The third rule is based on the fact that the molecule contains a halogenated aromatic ring, which is known to cause adverse effects related to immune system disorders.
4. The first rule is based on the fact that the molecule contains a carboxylic acid group, which is known to cause adverse effects related to immune system disorders. The second rule is based on the fact that the molecule contains a nitro group, which is known to cause adverse effects related to immune system disorders. The third rule is based on the fact that the molecule contains a halogenated aromatic ring, which is known to cause adverse effects related to immune system disorders.
5. The first rule is based on the fact that the molecule contains a carboxylic acid group, which is known to cause adverse effects related to immune system disorders. The second rule is based on the fact that the molecule contains a nitro group, which is known to cause adverse effects related to immune system disorders. The third rule is based on the fact that the molecule contains a halogenated aromatic ring, which is known to cause adverse effects related to immune system disorders.
6. The first rule is based on the fact that the molecule contains a carboxylic acid group, which is known to cause adverse effects related to immune system disorders. The second rule is based on the fact that the molecule contains a nitro group, which is known to cause adverse effects related to immune system disorders

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to immune system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to immune system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The provided molecule with label 1, CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O, contains a carboxylic acid group (-COOH). Therefore, it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: The provided molecule with label 1, CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)C(=O)NC)I)I, contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: The provided molecule with label 1, C1CCN(C[C@@H](C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F, contains a halogen atom (-Cl). Therefore, it is likely to cause adverse effects related to immune system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to immune system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with label 1, C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl, contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: The molecule with label 1, CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C, contains a carboxylic acid group (-COOH). Therefore, it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: The molecule with label 0, CCCCCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]5CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If a molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to immune system disorders.

================================

1. Rule 1: If the molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, then it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a piperazine group, then it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a functional group that is known to cause adverse effects on both the immune and nervous systems, such as a quinolone group, then it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, it is likely to cause adverse effects as well.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a carbamate group, it is likely to cause adverse effects as well.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the reproductive system, such as a phenol group, it is likely to cause adverse effects as well.
These rules are based on the observation that molecules containing these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not foolproof and there may be exceptions to each rule. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a sulfur atom (-S), it is likely to cause adverse effects related to immune system disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amide or a carboxylic acid, it is more likely to cause adverse effects related to immune system disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to immune system disorders.
3. Rule 3: If a molecule contains a nitro group, it is more likely to cause adverse effects related to immune system disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a piperazine group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the reproductive system, such as a maleic anhydride group, it is more likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to immune system disorders.
These rules are based on the observation that molecules with these functional groups are often associated with adverse effects related to immune system disorders. However, it is important to note that these rules are not always accurate and should be used as a starting point for further investigation.

================================

1. Rule 1: If the molecule contains an aromatic ring, it is more likely to cause adverse effects.
2. Rule 2: If the molecule has a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If the molecule has a high molecular weight, it is more likely to cause adverse effects.
Explanation:
1. Rule 1: The presence of an aromatic ring in a molecule can increase its lipophilicity, which can lead to increased absorption and distribution in the body. This can result in adverse effects such as toxicity, carcinogenicity, and genotoxicity.
2. Rule 2: Polar functional groups such as alcohols, aldehydes, and carboxylic acids can increase the polarity of a molecule, which can lead to increased absorption and distribution in the body. This can result in adverse effects such as toxicity, carcinogenicity, and genotoxicity.
3. Rule 3: High molecular weight molecules have a greater surface area to volume ratio, which can lead to increased absorption and distribution in the body. This can result in adverse effects such as toxicity, carcinogenicity, and genotoxicity.

================================

1. Rule 1: If a molecule contains an aromatic ring, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a polar functional group, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a charged group, it is more likely to cause adverse effects.
Explanation:
1. The first rule suggests that molecules with aromatic rings are more likely to cause adverse effects. This is because aromatic rings are highly stable and can interact with other molecules, which can lead to toxicity.
2. The second rule suggests that molecules with polar functional groups are more likely to cause adverse effects. Polar functional groups can interact with water and other molecules, which can lead to toxicity.
3. The third rule suggests that molecules with charged groups are more likely to cause adverse effects. Charged groups can interact with water and other molecules, which can lead to toxicity.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a metal ion such as platinum, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a carbamate group, it is more likely to cause adverse effects.

================================

1. Rule 1: If the molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, then it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a functional group that is known to cause adverse effects on the central nervous system, such as a piperazine group, then it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a functional group that is known to cause adverse effects on both the immune system and the central nervous system, such as a benzimidazole group, then it is likely to cause adverse effects.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, then it is likely to cause adverse effects as well.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a piperazine group, then it is likely to cause adverse effects as well.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the skin, such as a chlorobenzene group, then it is likely to cause adverse effects as well.
These rules are based on the observation that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not foolproof and there may be exceptions to them. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to immune system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to immune system disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to immune system disorders.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the immune system, such as a sulfonamide group, it is likely to cause adverse effects as well.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the nervous system, such as a carbamate group, it is likely to cause adverse effects as well.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the reproductive system, such as an estrogenic group, it is likely to cause adverse effects as well.
4. Rule 4: If a molecule contains a functional group that is known to cause adverse effects on the skin, such as a benzothiazole group, it is likely to cause adverse effects as well.
5. Rule 5: If a molecule contains a functional group that is known to cause adverse effects on the lungs, such as a quinolone group, it is likely to cause adverse effects as well.
6. Rule 6: If a molecule contains a functional group that is known to cause adverse effects on the liver, such as a nitro group, it is likely to cause adverse effects as well.
7. Rule 7: If a molecule contains a functional group that is known to cause adverse effects on the kidneys, such as a quinolone group, it is likely to cause adverse effects as well.
8. Rule 8: If a molecule contains a functional group that is known to cause adverse effects on the heart, such as a quinolone group, it is likely to cause adverse effects as well.
9. Rule 9: If a molecule contains a functional group that is known to cause adverse effects on the eyes, such as a benzothiazole group, it is likely to cause adverse effects as well.
10. Rule 10: If a molecule contains a functional group that is known to cause adverse effects on the blood, such as a quinolone group, it is likely to cause adverse effects as well.
11. Rule 11: If a molecule contains a functional group that is known to cause adverse effects on the skin, such as a benzothiazole group, it is likely to cause adverse effects as well.
12. Rule 12: If a molecule contains a functional group that is known to cause adverse effects on the lungs, such as a quinolone group, it is likely to cause adverse effects as well.
13. Rule 13: If a molecule contains a functional group

================================

